<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR66">
 <label>66.</label>
 <mixed-citation publication-type="other">Sanofi EL. FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma. Paris, 2019.</mixed-citation>
</ref>
